Fanconi Anemia Research Fund Welcomes Four New Board Members
The Fanconi Anemia Research Fund is very pleased to welcome new members Rachel Altmann, Nancy Golden, Andre Hessels, and Bill McCorey to the Board of Directors. The Fund’s board is comprised of community leaders and long-time supporters of the organization. The appointment of these four new members will strengthen the work of the board to advance the Fund’s mission. Experts in various fields, FARF looks forward to their individual talents and contributions.
Rachel Altmann; Portland, Ore.
Rachel has been active in the Fanconi anemia community for several years, as an FA parent, a contributor to FARF newsletters, and a fundraiser. She has worked in the education sector for many years, as an environmental educator at Hawai'i Nature Center and most recently as Library Outreach Specialist at Multnomah County Library in Portland, Ore. Her daughter, Nina, succumbed to complications from Fanconi anemia in 2006 at age three. Rachel continues to honor Nina’s legacy by working to advance FA research and support other families who face FA.
Nancy Golden; Springfield, Ore.
A pillar of the education community in Oregon, Nancy has served in a number of leadership roles, including Superintendent of Springfield School District, Chief Education Officer of the Oregon Education Investment Board, and Education Policy Advisor to Oregon Governor Kitzhaber. She is currently a professor of Practice, Educational Methodology, Policy and Leadership at the University of Oregon. A friend of the Frohnmayer family, Nancy has great respect for FARF and is looking forward to advancing the work of the organization.
Andre Hessels; Wayne, Penn.
Andre became involved with the Fund when his two children, Dylan and Joy, were diagnosed with FA in 2013. Since then, he has participated in numerous runs to raise funds, including the New York and Philadelphia marathons. Andre is a seasoned corporate financing specialist who currently works as VP Program Manager for Healthcare & Life Sciences at DLL Financial Services in Wayne, Penn. Originally from the Netherlands, Andre has worked in both Europe and North America as International Finance Manager for Rabobank. He brings a wealth of financial knowledge to the board and is looking forward to expanding his fundraising efforts.
Bill McCorey; Orlando, Fla.
Bill is a long-time FARF supporter, raising funds over the past decade with his annual event, Your Rope Team Mountain Climb. Bill is Senior Vice President and Chief Information Officer for Universal Parks and Resorts in Florida. Previously, he served as Vice President of Global Infrastructure for IBM. Bill is an avid supporter of local and global causes for children. He has completed 40 marathons, including 15 consecutive Boston Marathons. He is also an accomplished speaker who frequently speaks on the power of teams and is working on a book entitled “Who do you want on your rope team?”
Amy Frohnmayer Winn
It is with profound sorrow that we announce the loss of a truly beautiful, fierce, and compassionate soul, Amy Frohnmayer Winn, our dear friend, inspiration, and FARF board member. We pass along a message from Lynn Frohnmayer that was posted on Amy’s Caring Bridge site:
“’I hear a lot of words like "unfair" or "sorry." But if you think about it, aren't these all just bonus years? Am I not just extraordinarily lucky? In this moment, sipping coffee and watching dawn paint downtown Portland in pastels, there is nowhere else I'd rather be." (Two weeks ago)
Amy's capacity to feel gratitude and share love in the most dire of situations was on full display yesterday. The sudden onset of severe breathing problems and the diagnosis of pneumonia prompted her doctors to move her to the Intensive Care Unit where she could get additional breathing support. Friends from high school, Stanford and Portland happened to be visiting this weekend, and made regular trips back to her small cubicle in the ICU. Her exclamations of delight at seeing each visitor were vintage Amy: "It's so wonderful - to look up and see someone else I love walking through that door!" And "How lucky I am - to be surrounded by so many people I love." She expressed gratitude to each visitor- for cards, thoughtful gestures, friendship and love. She recalled minute details of time shared together.
We were all frantically worried, hoping against hope that strong antibiotics would quickly combat her pneumonia and we could soon return to the 14th floor, where a room had been saved for her.
But it was not to be. Throughout the evening her breathing became more labored. Surrounded by her devoted family, Amy passed away at 3:45 this morning. To say that we are all heartbroken, beside ourselves with grief doesn't adequately cover the excruciating sense of loss we feel. We are only comforted by the knowledge that she was surrounded by her devoted family, and the love in the room was palpable.
During the day Amy asked that I read several poems by Mary Oliver, a writer whose work Amy deeply admired. She has always found special meaning in the last phrases of "In Blackwater Woods":
To live in this world you must be able
to do three things:
to love what is mortal;
to hold it against your bones knowing
your own life depends on it;
and, when the time comes to let it go,
to let it go.
I am sure we won't ever be able to "let Amy go." Amy was our teacher, our guide, our inspiration, our love. Like so many of you, we all feel deeply grateful that this unique spirit touched our lives so profoundly. We are all determined to keep Amy forever in our hearts and try to embody, as best as we can, her love for nature, for cherished friends and family, and her enduring sense of gratitude for this far too short life she was given.”
Phil and Penny Knight Pledge Support for the David B. Frohnmayer Scientific Research Fund
EUGENE, Ore., April 5, 2016 – Phil and Penny Knight have pledged a gift of $10 million over the next ten years to support the David B. Frohnmayer Scientific Research Fund, a dedicated fund under the umbrella of the Fanconi Anemia Research Fund (FARF). The FARF Board of Directors established this special Fund to honor co-founder David Frohnmayer, who died in March 2015.
The Knight pledge is a cornerstone gift of FARF’s new $20 million campaign, according to FARF’s Executive Director, Pamela Norr. The campaign is committed to accelerating the pace of clinical trials, drug testing, gene therapies and more effective treatments for children and adults with Fanconi anemia (FA), she said. “A major focus of these game-changing initiatives will be preventing and curing the cancers that are now the primary cause of death in adults with FA. FARF has garnered initial gifts and pledges in excess of $12 million, all devoted exclusively to the Frohnmayer Scientific Research Fund.”
The Frohnmayer dedicated fund is intended to accelerate, not replace, FARF’s ongoing efforts to raise money each year to support scientific research grants and symposia, and to provide education and support services to families devastated by this disease.
“The urgency of this campaign to intensify scientific research is a direct consequence of FARF’s success. Fanconi anemia, once thought to be primarily a fatal bone marrow disorder of childhood, has now been unmasked as a DNA repair disorder that causes cancer in young adults,” said Grover C. Bagby, Jr., M.D., Chair Emeritus, OHSU Knight Cancer Institute. “Thanks in part to research supported by FARF, 80-94% of children with FA now survive bone marrow transplants. As adults, though, they are at extraordinarily high risk for developing cancer, at an average age of 33. Since they can’t tolerate chemotherapy, treatments that are effective for others are out of the question for them,” Bagby said.
As grim as this prognosis sounds, Bagby said, it comes in the midst of an explosion of FA research — especially research that leads to treatment. After 25 years devoted to identifying 19 FA genes, improving bone marrow transplants, and uncovering connections to breast and other cancers, FA scientists are now poised to create less toxic therapies that radically extend lives. These advances will help not only adults with FA, but millions of others with cancer.
“Cancer is the largest cause of death in the FA young adult population. It is my profound hope that this Fund in David’s honor will identify new, effective therapies to prevent and treat these cancers, and give young people with FA the chance to experience a full adulthood,” said Lynn Frohnmayer, FARF Co-founder.
“Phil and Penny Knight’s generosity is a fitting tribute to David,” said Frohnmayer. “More than financial, it is a gift of hope and compassion. It honors David’s boundless optimism and reinforces his firm conviction that dedicated people, working together, can change the world.”
The Fanconi Anemia Research Fund Announces Pamela Norr as Its New Executive Director
EUGENE, Ore., October 12, 2015 – The Fanconi Anemia Research Fund announces that Pamela Norr has been selected by the Board of Directors as the organization’s executive director, effective October 5, 2015. Norr replaces Laura Hays, PhD, who served as executive director for two and a half years and previously announced her resignation in August 2015.
Norr joins the Fund with 23 years of senior healthcare and nonprofit leadership experience, including most recently as Executive Officer of Oregon Rural Healthcare Quality Network (ORHQN), supporting Critical Access Hospitals throughout the state by quality benchmarking, case review and culture change for patient safety. Prior to ORHQN, she was the Executive Officer for Central Oregon Council On Aging for five years, helping seniors stay independent and secure. Her other experience includes a variety of senior management positions in hospital administration in nonprofit hospitals in California.
Pam received a BA in English from the University of Oregon and is a very active volunteer in community causes. She has served as a member on several boards and as a volunteer for many organizations, including the American Cancer Society, Alzheimer’s Association of Oregon, and the National Cooperative of Healthcare Networks.
Dave Frohnmayer, Co-founder of the Fanconi Anemia Research Fund, Passes Away
Frohnmayer Family Statement
March 10, 2015
Dave Frohnmayer passed away quietly in his sleep last night. He was 74. Dave had bravely dealt with his quiet battle against prostate cancer for 5 1/2 years. We are devastated by his passing but we are grateful that his passing was peaceful.
Much of Dave’s life was devoted to fighting devastating health crises that enveloped his family. These battles were complicated by the intense public attention that inevitably accompanied his lifelong commitment to public service. He was adamant that his own health issues would remain private. Except for the immediate family and Dave’s closest friends, he was able to accomplish this and continue a full public schedule to the end.
The family will hold a celebration of Dave’s remarkable life at a time to be announced.
Dave is survived by his wife Lynn, his sons Mark and Jonathan, his daughter Amy, his sister Mira and brother John. His daughters Kirsten and Katie and his brother Phil predeceased him.
#Contact: Marla Rae (503-931-0395); Bill Gary (541-954-0931)
Oregon to host Rose Bowl Touchdown Fan Challenge against Florida State
Eugene, Ore. – Oregon and Florida State will square off in the Rose Bowl on New Year’s Day as part of the inaugural College Football Playoff.
But each university has a common bond off the field that trumps the Ducks and Seminoles quest for victory – a cure against Fanconi anemia.
So for this College Football Playoff semifinal, Oregon and Florida State are hosting a head-to-head Touchdown Fan Challenge to support Fanconi anemia research.
Fans of No. 2 ranked Oregon can support the Ducks by pledging to donate a dollar amount of their choosing for each Oregon touchdown by visiting pldgit.com/rosebowl2015.
Former University of Oregon President Dave Frohnmayer and his wife Lynn have a 27-year-old daughter, Amy, with Fanconi anemia and lost two other children to this deadly rare disease.
So in 1989 the Frohnmayers became co-founders of The Fanconi Anemia Research Fund to fund grants for critical FA efforts and to support affected families.
Over the past quarter century, FARF has raised more than $29 million to support families and fund more than 100 doctors and researchers worldwide all racing to find a cure.
All funds raised by Oregon as part of this head-to-head Touchdown Pledge Challenge for the Rose Bowl will benefit FARF.
“Because of these aggressive efforts, we’re beginning to find ways to combat this disease that was once a total mystery and an immediate death sentence for children,” Frohnmayer said.
Florida State also has a strong tie to this deadly rare disease. Less than four years ago Seminoles’ head coach Jimbo Fisher and his wife Candi were told their 9-year-old son, Ethan, had Fanconi anemia.
The Fishers started Kidz1stFund shortly after Ethan was diagnosed. And in less than four years Kidz1stFund has donated $2.8 million directly to Fanconi anemia research.
“It’s a terrible fate our families share, but one we use to fuel our fight against FA,” coach Fisher said. “With the nation’s attention on the Rose Bowl, we have both an opportunity and responsibility to raise awareness for a much more critical victory in our sights.”